Related references
Note: Only part of the references are listed.Somatic oncogenic mutations, benign skin lesions and cancer progression: Where to look next?
Agusti Toll et al.
CELL CYCLE (2008)
Role of FGFR3 in urothelial cell carcinoma: biomarker and potential therapeutic target
Margaret A. Knowles
WORLD JOURNAL OF UROLOGY (2007)
Selective over-expression of fibroblast growth factor receptors 1 and 4 in clinical prostate cancer
K. Sahadevan et al.
JOURNAL OF PATHOLOGY (2007)
Fibroblast growth factor receptor signaling through MEK-ERK is required for prostate bud induction
Sheri L. Kuslak et al.
DIFFERENTIATION (2007)
Oncogenic PIK3CA mutations occur in epidermal nevi and seborrheic keratoses with a mutation pattern
Christian Hafner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
FGFR3 mutations in seborrheic keratoses are already present in flat lesions and associated with age and localization
Christian Hafner et al.
MODERN PATHOLOGY (2007)
Conditional activation of FGFR1 in the prostate epithelium induces angiogenesis with concomitant differential regulation of Ang-1 and Ang-2
S. F. Winter et al.
ONCOGENE (2007)
Fibroblast growth factor receptor 3 mutations in epidermal nevi and associated low grade bladder tumors
Silvia Hernandez et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2007)
Fibroblast growth factor receptor 2 tyrosine kinase is required for prostatic morphogenesis and the acquisition of strict androgen dependency for adult tissue homeostasis
Yongshun Lin et al.
DEVELOPMENT (2007)
Cancer statistics, 2007
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2007)
FGFR3 mutations in benign skin tumors
Christian Hafner et al.
CELL CYCLE (2006)
High frequency of FGFR3 mutations in adenoid seborrheic keratoses
Christian Hafner et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2006)
Concomitant down-regulation of SPRY1 and SPRY2 in prostate carcinoma
S. Fritzsche et al.
ENDOCRINE-RELATED CANCER (2006)
Prospective study of FGFR3 mutations as a prognostic factor in nonmuscle invasive urothelial bladder carcinomas
Silvia Hernandez et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Mosaicism of activating FGFR3 mutations in human skin causes epidermal nevi
Christian Hafner et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Oncogenic properties of the mutated forms of fibroblast growth factor receptor 3b
I Bernard-Pierrot et al.
CARCINOGENESIS (2006)
FGFR3 dimer stabilization due to a single amino acid pathogenic mutation
E Li et al.
JOURNAL OF MOLECULAR BIOLOGY (2006)
FGFR3 and Tp53 mutations in T1G3 transitional bladder carcinomas:: Independent distribution and lack of association with prognosis
S Hernández et al.
CLINICAL CANCER RESEARCH (2005)
Activating mutations of the tyrosine kinase receptor FGFR3 are associated with benign skin tumors in mice and humans
A Logié et al.
HUMAN MOLECULAR GENETICS (2005)
FGF signaling in the developing endochondral skeleton
DM Ornitz
CYTOKINE & GROWTH FACTOR REVIEWS (2005)
Epigenetic inactivation of the human sprouty2 (hSPRY2) homologue in prostate cancer
AB McKie et al.
ONCOGENE (2005)
Genomics of prostate cancer: Is there anything to translate?
L Kopper et al.
PATHOLOGY & ONCOLOGY RESEARCH (2005)
The expression of sprouty1, an inhibitor of fibroblast growth factor signal transduction, is decreased in human prostate cancer
B Kwabi-Addo et al.
CANCER RESEARCH (2004)
Fibroblast growth factor 17 is over-expressed in human prostate cancer
R Heer et al.
JOURNAL OF PATHOLOGY (2004)
Directionally specific paracrine communication mediated by epithelial FGF9 to stromal FGFR3 in two-compartment premalignant prostate tumors
CL Jin et al.
CANCER RESEARCH (2004)
Molecular grading of urothelial cell carcinoma with fibroblast growth factor receptor 3 and MIB-1 is superior to pathologic grade for the prediction of clinical outcome
BWG van Rhijn et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease
DM Ornitz et al.
GENES & DEVELOPMENT (2002)
Frequency of fibroblast growth factor receptor 3 mutations in sporadic tumours
K Sibley et al.
ONCOGENE (2001)
Increased expression of FGF-8 isoforms and FGF receptors in human premalignant prostatic intraepithelial neoplasia lesions and prostate cancer
EM Valve et al.
LABORATORY INVESTIGATION (2001)
Frequent FGFR3 mutations in papillary non-invasive bladder (pTa) tumors
C Billerey et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Role of androgens and fibroblast growth factors in prostatic development
AA Thomson
REPRODUCTION (2001)
Share Paper
